NY Stem Cell Foundation partners with PPMI

Last week, The New York Stem Cell Foundation (NYSCF) Research Institute announced in a press release that they will partner with PPMI to generate stem cell lines from PPMI participants.  As part of the mission of PPMI to accelerate biomarker verification and drug development, these stem cell lines will be made available to the scientific community at large.  The stem cell lines will used to understand the etiology and progression of the disease as compared to the existing and future biomarker data in the PPMI database.  NYSCF’s Global Stem Cell Array is an automated robotic platform that makes it possible to create identical stem cell lines from a large number of patients.  They will create disease models using iPS cell-derived, dopamine-producing cells, known as dopaminergic neurons, which degenerate in Parkinson’s disease.  By examining these pathological changes in the disease models, scientists can better understand the pathology of PD, which can identify potential drug targets.  The press release was picked up by News Medical, Eureka Alert!, and DDNews.

To read the press release, click here.